Skip to content
healthcare.dev

Liothyronine Sodium

NDC 68788-7269, Liothyronine Sodium, tablet, from Preferred Pharmaceuticals Inc..

Product NDC
68788-7269
Status
Listed
Labeler
Preferred Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA200295
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68788-7269 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIOTHYRONINE SODIUM5 ug/1

Pharmacologic classes

Triiodothyronine [CS]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
68788-7269-36878872690330 TABLET in 1 BOTTLE (68788-7269-3)
68788-7269-66878872690660 TABLET in 1 BOTTLE (68788-7269-6)
68788-7269-96878872690990 TABLET in 1 BOTTLE (68788-7269-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/57744c7c-af44-4bc4-a5a8-79f05710f469

Use it

Look up 68788-7269 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68788-7269 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68788-7269. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.